About us
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
The GA4GH Council, consisting of the Executive Committee, Strategic Leadership Committee, and Product Steering Committee, guides our collaborative, globe-spanning alliance.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across a number of Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
The Technical Alignment Subcommittee (TASC) supports harmonisation, interoperability, and technical alignment across GA4GH products.
Find out what’s happening with up to the minute meeting schedules for the GA4GH community.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Want to advance both your career and responsible genomic data sharing at the same time? See our open leadership opportunities.
Join our international team and help us advance genomic data use for the benefit of human health.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
5 Aug 2019
Under the GDPR, organizations within a given sector or representative body can develop Codes of Conduct to help overcome key data protection challenges. Developing an approved Code is a serious endeavour and difficult to achieve, but can be of great benefit, including by better enabling responsible international data sharing in genomics and health-related research. Such Codes complement rather than supersede the GDPR.
Under the GDPR, organizations within a given sector or representative body can develop Codes of Conduct to help overcome key data protection challenges. Developing an approved Code is a serious endeavour and difficult to achieve, but can be of great benefit, including by better enabling responsible international data sharing in genomics and health-related research. Such Codes complement rather than supersede the GDPR.
In June 2019, the European Data Protection Board (“EDPB”) released its Guidelines on Codes of Conduct and Monitoring Bodies under the GDPR. These 30-page Guidelines offer pertinent information regarding, among other things, the conditions to be met before a competent Data Protection Supervisory Authority (“DPA”) in the EU would be in a position to assess and review a Code for the purposes of the GDPR, and the criteria organizations will need to meet to have their Code approved.
As the Guidance notes, under the GDPR, organizations are encouraged to draft Codes of Conduct, which are voluntary accountability tools that can represent a practical, potentially cost-effective, and meaningful method to achieve greater levels of consistency of protection for data protection rights. Codes can act as a mechanism to demonstrate compliance with the GDPR. Importantly, transnational Codes can help to bridge the harmonization gaps that may exist between EU Member States in their application of data protection law. They also provide an opportunity for particular sectors, such as the life sciences sector, to reflect upon common data processing activities and to agree to tailored and practical data protection rules, which will meet the needs of the sector as well as the requirements of the GDPR.
As provided by the non-exhaustive list contained in Article 40(2) of the GDPR, Codes may notably cover topics such as:
Notably, one of the example boxes in the EDPB’s Guidelines describes the benefit of a Code “in the context of processing health data for research purposes”. Appendix 3 provides a checklist for organizations to use before submitting a draft Code for approval to a competent DPA.
As the Guidelines note, “Codes may also prove to be a significant and useful mechanism in the area of international transfers.” A Code can demonstrate that a sector has appropriate safeguards to transfer data to countries outside the EU and thus enable organizations to share data internationally. Under Article 46, an organization can transfer personal data to a non-EU country without requiring any specific authorization from a DPA where there is an approved Code of Conduct pursuant to Article 40, together with binding and enforceable commitments of the controller or processor in the non-EU country to apply the appropriate safeguards, including as regards data subjects’ rights. The EDPB notes in the Guidelines that it will provide separate guidelines in the future in relation to the use of Codes as a mechanism to facilitate international data transfers.
While BBMRI-ERIC is currently drafting a Code of Conduct for Health Research for its members, other organizations or representative bodies in genomics and health-related research, including industry, may wish to draw up Codes tailored to their particular sectoral needs. Given the challenges associated with developing Codes of Conduct (including the need for Codes to contain mechanisms that enable an accredited monitoring body to carry out mandatory monitoring and compliance), organizations are encouraged to seek legal advice when considering whether to draft one. This is particularly so given that the EDPB’s Guidelines emphasize a Code’s potential to “establish a set of rules”, rather than simply assisting compliance with the existing rules of the GDPR.
Further Reading
Relevant GDPR Provisions
Edward Dove is a Lecturer in Law at the University of Edinburgh.
See all previous briefs.
Please note that GDPR Briefs neither constitute nor should be relied upon as legal advice. Briefs represent a consensus position among Forum Members regarding the current understanding of the GDPR and its implications for genomic and health-related research. As such, they are no substitute for legal advice from a licensed practitioner in your jurisdiction.